TSURUHA Holdings, Inc.
TTSE:33912,182.50
JPY
-3.00
(-0.14%)
ISIN
JP3536150000
Return %
Stock
S&P 500
1Y
-17.98
14.20
3Y
3.63
81.12
5Y
-20.92
68.34
Capital Structure
JPY
•
in mil. unless spec.Working Capital
JPY
•
in mil. unless spec.Growth Rates
JPY
•
in mil. unless spec.Quarterly Revenue
JPY
•
in mil. unless spec.Quarterly Earnings Per Share
JPY
•
in mil. unless spec.Quarterly Dividends Per Share
JPY
•
in mil. unless spec.Company Description
- CEO
- Jun Tsuruha
- Full Time Employees
- 27,681
- Sector
- Retail trade
- Industry
- Drugstore chains
- Address
- 20-1-21, Kita 24 Johigashi Sapporo HO Japan 065-0024
- IPO Date
- Nov 16, 2005
- Website
- tsuruha-hd.co.jp
- Similar Companies
- Business
- Tsuruha Holdings Inc. operates primarily as a holding company managing subsidiaries that operate a wide network of drugstores across Japan. Its core products and services include retail sales of pharmaceuticals, prescription medicines, over-the-counter drugs, cosmetics, health foods, dietary supplements, daily necessities, and miscellaneous goods. The company also provides dispensing pharmacy services, pharmaceutical training and counseling, private brand product development and sales promotion, mail order services, insurance agency services, and real estate leasing related to its retail operations. Tsuruha manages its drugstore chains and dispensing pharmacies concentrated in key Japanese regions including Hokkaido, Tohoku, Kanto, Koshinetsu, Chugoku, Kyushu, and major prefectures like Shizuoka, Aichi, and Hiroshima. Founded in 1963 and headquartered in Sapporo, Japan, Tsuruha Holdings serves a broad customer base that includes retail consumers seeking healthcare and lifestyle products, as well as patients requiring pharmaceutical dispensing services. The company operates through several business divisions such as Drugstore, Dispensing, Nursing, Mail Order, and Group Support businesses, with a workforce exceeding 11,000 employees. In the most recent major developments, Tsuruha Holdings is undergoing a significant business integration with WELCIA HOLDINGS CO., LTD. via a stock swap scheduled for December 2025, followed by a tender offer completion by AEON CO., LTD. in January 2026, after which Tsuruha is expected to announce a new Medium-Term Management Plan outlining its post-integration strategy and growth objectives. This integration aims to expand its scale and competitiveness in Japan’s drugstore sector. Additionally, Tsuruha plans to launch new private brand products in spring 2026 in collaboration with Welcia. The company maintains a strong cash position to support its integration and continuous investments in store expansions and renovations. Tsuruha also backs AEON’s tender offer, positioning itself for a closer strategic alliance with AEON Group in its growth trajectory. Overall, Tsuruha Holdings is a leading player in Japan’s consumer health retail and pharmaceutical dispensing sectors, operating with a broad product portfolio and regional presence, and currently in a strategic phase of consolidation and expansion through partnership and integration with major industry players.